Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer.

about

Palliative treatment with carboplatin as late line therapy to patients with metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q50087231

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Palliative treatment with carb ...... with metastatic breast cancer.

@en

Palliative treatment with carb ...... with metastatic breast cancer.

@nl

type

Item

label

Palliative treatment with carb ...... with metastatic breast cancer.

@en

Palliative treatment with carb ...... with metastatic breast cancer.

@nl

prefLabel

Palliative treatment with carb ...... with metastatic breast cancer.

@en

Palliative treatment with carb ...... with metastatic breast cancer.

@nl

P1476

Palliative treatment with carb ...... with metastatic breast cancer.

@en

P2093

Anders B Jensen

http://www.w3.org/2001/XMLSchema#string

Lena H Rosvig

http://www.w3.org/2001/XMLSchema#string

Sven T Langkjer

http://www.w3.org/2001/XMLSchema#string

P2860

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.

Carboplatin: an active drug in metastatic breast cancer.

Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.

Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.

Carboplatin plus gemcitabine repeating doublet therapy in recurrent breast cancer.

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes.

Carboplatin activity in untreated metastatic breast cancer patients--results of a phase II study.

Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.

P304

156-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1407495

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ann Knoop

P577

2017-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29202627

http://www.w3.org/2001/XMLSchema#string